Kappadione
![]() | |
| Systematic (IUPAC) name | |
|---|---|
|
Tetrasodium (2-methyl-4-phosphonatooxynaphthalen-1-yl) phosphate | |
| Clinical data | |
| Routes of administration | Injection |
| Legal status | |
| Legal status |
|
| Identifiers | |
| CAS Number |
131-13-5 6700-42-1 (hexahydrate) |
| ATC code | none |
| PubChem | CID 8555 |
| ChemSpider |
8237 |
| UNII |
2OVL75B30W |
| Chemical data | |
| Formula | C11H8Na4O8P2 |
| Molar mass | 422.08 g/mol |
| |
| |
| | |
Kappadione is a Vitamin K derivative. It was manufactured by Eli Lilly and Company.[1] Chemically, it is menadiol sodium diphosphate.
References
- ↑ "Kappadione overview, medicine.org". Retrieved 2008-04-14.
This article is issued from Wikipedia - version of the Tuesday, April 05, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
